Pedrinelli R, Magagna A, Arzilli F, Sassano P, Salvetti A
Clin Pharmacol Ther. 1980 Dec;28(6):722-31. doi: 10.1038/clpt.1980.227.
The effect of bumetanide on absolute and fractional sodium excretion, creatinine clearance, and plasma renin activity (PRA) was studied in eight patients with essential hypertension before and after indomethacin. After bumetanide, urinary sodium excretion increased only in the first 4 hr, creatinine clearance only in the first 2 hr, and PRA rose progressively. After indomethacin, bumetanide caused a smaller increase in urinary sodium excretion, decreased creatinine clearance, and caused a small early and late PRA rise. Prostaglandin inhibition and indomethacin did not, per se, affect the tubular natriuretic mechanism but they abolished both early vascular and sustained PRA-stimulating effects of bumetanide.
在8例原发性高血压患者中,研究了消炎痛应用前后布美他尼对绝对和分数钠排泄、肌酐清除率及血浆肾素活性(PRA)的影响。给予布美他尼后,尿钠排泄仅在最初4小时增加,肌酐清除率仅在最初2小时增加,而PRA则逐渐升高。给予消炎痛后,布美他尼使尿钠排泄增加幅度减小,肌酐清除率降低,并使PRA在早期和晚期均有小幅升高。前列腺素抑制及消炎痛本身并不影响肾小管利钠机制,但它们消除了布美他尼早期的血管作用及持续的PRA刺激作用。